Hauser, RA, L Zeitlin, S Fisher, and R D’Souza. 2020. “Carbidopa and Levodopa Extended Release Capsules (Rytary®) in Patients With and Without Troublesome and Non-Troublesome Dyskinesia. J Parkinsons Dis 2020;10:915-925.”. J Parkinsons Dis.
Publications
2020
LeWitt, PA, S Kymes, and RA Hauser. 2020. “Parkinson Disease and Orthostatic Hypotension in the Elderly: Recognition and Management of Risk Factors for Falls. Aging Dis 2020;11:679-691.”. Aging Dis.
Wallace, DM, WK Wohlgemuth, LM Trotti, AW Amara, IA Malaty, SA Factor, S Nallu, L Wittine, RA Hauser, and DM Wall. 2020. “Practical Evaluation and Management of Insomnia in Parkinson’s Disease: A Review. Mov Disord Clin Pract 2020;7:250-266.”. Mov Disord Clin Pract.
Tanner, CM, R Pahwa, RA Hauser, WH Oertel, SH Isaacson, J Jankovich, R Johnson, D Chernick, and J Hubble. 2020. “EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease. J Parkinsons Dis 2020;10:543-558.”. J Parkinsons Dis.
2019
Hermanowicz, N, SA Jones, and RA Hauser. 2019. “Impact of Non-Motor Symptoms in Parkinson’s Disease: A PMDAlliance Survey. Neuropsychiatr Dis Treat 2019;15:2205-2212.”. Neuropsychiatry Dis Treat.
Fernandez, HH, D Stamler, MD Davis, SA Factor, RA Hauser, J Jimenez-Shahed, WG Ondo, LF Jarskog, SW Woods, and D Bega. 2019. “Long-Term Safety and Efficacy of Deutetrabenazine for the Treatment of Tardive Dyskinesia. J Neurol Neurosurg Psychiatry 2019;90:1317-1323.”. J Neurol Neurosurg Psychiatry.
Vollstedt, EJ, M Kasten, C Klein, and MJFF Global Genetic Parkinson’s Disease Study Group. 2019. “Using Global Team Science to Identify Genetic Parkinson’s Disease Worldwide. Ann Neurol 2019;86:153-157.”. Ann Neurol.
Hauser, RA, DE Kremens, LW Elmer, DL Kreitzman, RR Walsh, R Johnson, R Howard, JT Nguyen, and R Patni. 2019. “Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials. J Parkinsons Dis 2019;9:591-600.”. J Parkinsons Dis.
Hauser, RA, SH Isaacson, A Ellenbogen, BE Safirstein, DD Truong, SF Komjathy, DM Kegler-Ebo, P Zhao, and C Oh. 2019. “Orally Inhaled Levodopa (CVT-301) for Early Morning OFF Periods in Parkinson’s Disease. Parkinsonism Relat Disord 2019;64:175-180.”. Parkinsonism Relat Disord.